Apollomics Inc. (APLM)
APLM trades on Nasdaq in Health Care, Biotechnology: Pharmaceutical Preparations. Numbers below come from the Nasdaq screener and SEC filings, each with its source.
Price · October 14, 2026
$21.32
0.00% on the day
Market cap
$61.7M
Micro cap
Revenue · 2024
$0
No prior year to compare
Net income · 2024
-$53.9M
Price, change, market cap, sector and industry: Nasdaq stock screener, as of October 14, 2026. Revenue: SEC 20-F (ifrs-full:Revenue), period ending 2024-12-31, https://www.sec.gov/Archives/edgar/data/1944885/000095017025050531/0000950170-25-050531-index.htm. Net income: SEC 20-F (ifrs-full:ProfitLoss), period ending 2024-12-31.
Profile
| Field | Value |
|---|---|
| Ticker | APLM on Nasdaq |
| Sector | Health Care |
| Industry | Biotechnology: Pharmaceutical Preparations |
| Country | United States |
| IPO year | Not reported by the screener |
| SEC CIK | 0001944885 |
| SEC industry code | Pharmaceutical Preparations |
| Incorporated in | E9 |
Financials · 2024
| Line | Value |
|---|---|
| Revenue | $0 |
| Net income | -$53.9M |
| Operating income | Not in SEC XBRL data |
| Net margin | Needs revenue and net income |
| Operating margin | Operating income not reported |
| Revenue growth | No prior-year revenue to compare |
| Cash | Not in SEC XBRL data |
| Total assets | Not in SEC XBRL data |
| P/E (computed) | Net income was not positive |
| P/S (computed) | Needs market cap and revenue |
Key SEC documents
| Document | Form | Filed |
|---|---|---|
| Latest prospectus or offering document | 424B3 | 2026-09-08 |
| Latest annual report | 20-F | 2026-04-24 |
| Latest quarterly / interim | 6-K | 2026-08-12 |
Source: SEC EDGAR submissions feed, 183 recent filings. All filings on EDGAR.
Peers in Biotechnology: Pharmaceutical Preparations
| Ticker | Company | Price | Day | Market cap |
|---|---|---|---|---|
| GANX | Gain Therapeutics Inc. | $1.41 | -10.19% | $61.5M |
| VRCA | Verrica Pharmaceuticals Inc. | $3.58 | -10.72% | $61.5M |
| XLO | Xilio Therapeutics Inc. | $9.22 | +1.60% | $60.7M |
| PLRX | Pliant Therapeutics Inc. | $0.9680 | -1.83% | $59.9M |
| TENX | Tenax Therapeutics Inc. | $1.60 | -12.57% | $59.9M |
| GOSS | Gossamer Bio Inc. | $9.76 | +5.17% | $59.7M |
| ONCY | Oncolytics Biotech Inc. | $0.4900 | +3.53% | $64.2M |
| SDEV | Stablecoin Development Corporation | $1.25 | -11.35% | $64.7M |
The full dossier has every filing, three years of financials, private raises and the people who signed them.
Open the full dossier